Imagine that you want to know the plot of a movie, but you only have access to either the visuals or the sound. With visuals ...

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform PR Newswire FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 ...

Genome Research publishes Part 2 of the Special Issue on Long-read DNA and RNA Sequencing Applications in Biology and Medicine, a diverse collection of research, methods, and review articles ...

At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.

FREMONT, Calif., Jan. 9, 2025 /PRNewswire/ -- Ultima Genomics, Inc., a developer of an ultra-high throughput next-generation sequencing (NGS) platform, today announced that its UG 100 ™ was ...

Summary Illumina sequencing, a hallmark of second-generation sequencing technology, has revolutionized genomics research. This method employs a sophisticated reversible dye terminator technology to ...

During the next two decades, sequencers went through rapid evolution, optimizing, to different extents, parameters such as speed, accuracy, sequencing depth and read length.4 A variety of sequencing ...

A new clinical RNA sequencing platform at The Hospital for Sick Children (SickKids) is helping to facilitate research into rare genetic conditions and carve a path for Precision Child Health, a ...

A clinical RNA sequencing platform at SickKids, the first of its kind in Canada, offers insights into complex genetic conditions and the future of precision diagnostics.